Advancing Smokeless Tobacco Product Assessment
Advancing Smokeless Tobacco Product Assessment
In the realm of tobacco product assessment and comparison, the development of precise dissolution testing methods plays a crucial role. These methods enable us to gauge the release profiles of substances like nicotine from various smokeless tobacco products.
To ensure accuracy in quantifying the released nicotine, a sensitive Ultra Performance Liquid Chromatography coupled to a Photodiode Array detector (UPLC-PDA) method was created and validated. This method effectively measures nicotine release into artificial saliva, the chosen dissolution medium.
The practicality of the validated method was demonstrated by examining nicotine release profiles from a range of commercial and CORESTA reference smokeless tobacco products. These included CRP 1.1 (Swedish-style snus pouch), CRP 2.1 (American-style loose moist snuff), CRP 4 (loose-leaf chewing tobacco), and CRP 4.1 (chopped loose-leaf chewing tobacco).
To analyze these profiles, factors like the difference factor (f1) and similarity factor (f2) were employed following FDA’s Center for Drug Evaluation and Research (CDER) guidelines. A first-order kinetic model was also used to fit the release profile curves.
Findings revealed that nicotine release is influenced by the form and cut of smokeless tobacco products, with snus and loose-leaf variants exhibiting slower release rates compared to chopped and loose moist snuff.
Importantly, this dissolution methodology has the potential to be expanded for measuring and comparing the release of other constituents from smokeless tobacco products, offering a pathway to method standardization.
This research not only enhances our understanding of smokeless tobacco products but also provides a valuable tool for product evaluation and comparison, ultimately contributing to informed consumer choices and regulatory standards.
